InsiderTrades

Form 4 for CADL Candel Therapeutics, Inc.

Accepted 2024-12-26 00:00:00 ET · period of report 2024-12-20 · accession 0001873919-24-000010 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
MI 2024-12-26 2024-12-20+ CADL Aguilar Laura K. 10% D - Sale to Iss $8.84 -200.0K 231.4K -46% -$1.77M
M 2024-12-26 2024-12-20+ CADL Aguilar Laura K. 10% D - Sale to Iss $8.84 -100.0K 373.5K -21% -$883.5K

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common CADL 2024-12-20 D D 100,000 $9.00 331,443 I By LKA 2022 Revocable Trust — — (F1) Shares of common stock held by spouse LKA 2022 Revocable trust
2 Common CADL 2024-12-23 D D 50,000 $8.52 323,512 D By LKA 2022 Revocable Trust — — (F1) Shares of common stock held by spouse LKA 2022 Revocable trust
3 Common CADL 2024-12-23 D D 50,000 $8.52 281,443 I — —
4 Common CADL 2024-12-24 D A 50,000 $8.82 273,512 D — —
5 Common CADL 2024-12-20 D D 100,000 $9.00 373,512 D By LKA 2022 Revocable Trust — — (F1) Shares of common stock held by spouse LKA 2022 Revocable trust
6 Common CADL 2024-12-24 D D 50,000 $8.82 231,443 I — —